Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach
Background: Transplant centers saw a substantial reduction in deceased donor solid organ transplantation since the beginning of the coronavirus 2019 (COVID-19) pandemic in the United States. There is limited data on the impact of COVID-19 on adult and pediatric heart transplant volume and variation...
Guardado en:
Autores principales: | Awais Ashfaq, MD, Geoffrey M. Gray, PhD, Jennifer Carapellucci, Ernest K. Amankwah, PhD, Luis M. Ahumada, PhD, Mohamed Rehman, MD, Michael Puchalski, MD, Andrew Smith, MD, James A. Quintessenza, MD, Alfred Asante-Korang, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b0aba24f40143519743ce9ed3a781e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
por: Christina Routsi, MD, PhD, et al.
Publicado: (2021) -
Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
por: Kazuki Takada, MD, PhD, et al.
Publicado: (2021) -
Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People
por: Naoki Tanimine, MD, PhD, et al.
Publicado: (2021) -
Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Nikolai Ravn Aarskog, MD, et al.
Publicado: (2021) -
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021)